Spectral Medical Overview
- Year Founded
-
1991
- Status
-
Public
- Employees
-
29
- Stock Symbol
-
EDT
- Investments
-
1
- Share Price
-
$0.70
- (As of Friday Closing)
Spectral Medical General Information
Description
Spectral Medical Inc is focused on the development and commercialization of a treatment for septic shock utilizing its endotoxin activity assay (EAA) diagnostic and the Toraymyxin therapeutic. The company also manufactures and sells proprietary reagents. The product line of the company consists of proprietary biochemical, EAA, and instrumentation. Its products include an endotoxin activity assay, a rapid in-vitro diagnostic test used to measure endotoxin levels in blood, and a polymyxin B hemoperfusion device designed to remove endotoxin from the bloodstream. The company's proprietary reagents include recombinant proteins, antibodies, and calibrators used in research and diagnostic applications.
Contact Information
Website
www.spectraldx.comCorporate Office
- 135 The West Mall
- Unit 2
- Toronto, Ontario M9C 1C2
- Canada
Corporate Office
- 135 The West Mall
- Unit 2
- Toronto, Ontario M9C 1C2
- Canada
Spectral Medical Stock Performance
As of 13-Nov-2026, Spectral Medical’s stock price is $0.70. Its current market cap is $206M with 294M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.70 | $0.72 | $0.61 - $1.11 | $206M | 294M | 51.1K |
Spectral Medical Financials Summary
As of 30-Sep-2026, Spectral Medical has a trailing 12-month revenue of $1.56M.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 252,655 | 314,813 | 103,867 | 94,954 |
| Revenue | 1,563 | 1,746 | 1,667 | 1,183 |
| EBITDA | 4,847 | (30,229) | (8,727) | (10,333) |
| Net Income | (249) | (34,102) | (11,232) | (11,597) |
| Total Assets | 2,092 | 4,454 | 3,707 | 3,928 |
| Total Debt | 18,611 | 15,399 | 10,399 | 6,453 |
Spectral Medical Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Spectral Medical Comparisons
Industry
Financing
Details
Spectral Medical Competitors (7)
One of Spectral Medical’s 7 competitors is Boston Scientific, a Corporation company based in Marlborough, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Boston Scientific | Corporation | Marlborough, MA | ||||
| Urologix | Formerly VC-backed | Minneapolis, MN | ||||
| Abiomed | Corporate Backed or Acquired | Danvers, MA | ||||
| Globus Medical | Formerly VC-backed | Audubon, PA | ||||
| Endologix | Corporation | Santa Rosa, CA |
Spectral Medical Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Spectral Medical Patents
Spectral Medical Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2016109875-A1 | Endotoxin biosensor, neutralization cartridge and processes for manufacturing same | Inactive | 07-Jan-2015 | ||
| US-20070254322-A1 | Complement-based analyte assay | Inactive | 01-May-2006 | ||
| US-5702905-A | Specificity, sensitivity; diagnosis of cardiac muscle damage | Inactive | 28-Sep-1994 | C07K16/18 |
Spectral Medical Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Spectral Medical Investments (1)
Spectral Medical’s most recent deal was a Joint Venture with i-Dialco. The deal was made on 13-Dec-2022.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| i-Dialco | 13-Dec-2022 | Joint Venture | Diagnostic Equipment |
Spectral Medical ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Healthcare
Industry
Rank
Percentile
Medical Devices
Subindustry
Rank
Percentile
Spectral Medical FAQs
-
When was Spectral Medical founded?
Spectral Medical was founded in 1991.
-
Where is Spectral Medical headquartered?
Spectral Medical is headquartered in Toronto, Canada.
-
What is the size of Spectral Medical?
Spectral Medical has 29 total employees.
-
What industry is Spectral Medical in?
Spectral Medical’s primary industry is Diagnostic Equipment.
-
Is Spectral Medical a private or public company?
Spectral Medical is a Public company.
-
What is Spectral Medical’s stock symbol?
The ticker symbol for Spectral Medical is EDT.
-
What is the current stock price of Spectral Medical?
As of 13-Nov-2026 the stock price of Spectral Medical is $0.70.
-
What is the current market cap of Spectral Medical?
The current market capitalization of Spectral Medical is $206M.
-
What is Spectral Medical’s current revenue?
The trailing twelve month revenue for Spectral Medical is $1.56M.
-
Who are Spectral Medical’s competitors?
Boston Scientific, Urologix, Abiomed, Globus Medical, and Endologix are some of the 7 competitors of Spectral Medical.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
